PDL BIOPHARMA
PDL BioPharma, Inc. engages in intellectual property asset management, and patent portfolio and related assets investment activities. Intellectual Property Patents The company has been issued patents in the United States and elsewhere, covering the humanization of antibodies, which are referred to as its Queen et al. patents.The company was founded as a Delaware corporation in 1986 under the name Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006.
PDL BIOPHARMA
Industry:
Biotechnology Health Care Medical
Founded:
1986-01-01
Address:
Incline Village, Nevada, United States
Country:
United States
Website Url:
http://www.pdl.com
Total Employee:
251+
Status:
Closed
Contact:
775-832-8500
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 IIS IIS 8 Network Solutions DNS Akamai Hosted CodeTwo IHS Markit
Similar Organizations
Henry Ford Health System
Henry Ford Health System (HFHS) is one of the nation’s leading comprehensive, integrated health systems.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Current Employees Featured
Founder
Stock Details
Company's stock symbol is NASDAQ:PDLI
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2005-01-27 | ESP Pharma | ESP Pharma acquired by PDL Biopharma | 475 M USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-06-10 | Evofem Biosciences | PDL Biopharma investment in Post-IPO Equity - Evofem Biosciences | 50 M USD |
| 2019-04-01 | Evofem Biosciences | PDL Biopharma investment in Post-IPO Equity - Evofem Biosciences | 30 M USD |
| 2016-05-25 | Noden Pharma | PDL Biopharma investment in Corporate Round - Noden Pharma | 107 M USD |
| 2014-04-07 | kaleo | PDL Biopharma investment in Debt Financing - kaleo | 150 M USD |
| 2014-02-23 | Paradigm Spine | PDL Biopharma investment in Debt Financing - Paradigm Spine | 75 M USD |
| 2014-02-18 | Direct Flow Medical | PDL Biopharma investment in Debt Financing - Direct Flow Medical | 50 M USD |
| 2013-11-07 | Durata Therapeutics | PDL Biopharma investment in Post-IPO Equity - Durata Therapeutics | 70 M USD |
| 2013-10-02 | LENSAR, Inc. | PDL Biopharma investment in Venture Round - LENSAR, Inc. | 27 M USD |
| 2013-10-02 | LENSAR, Inc. | PDL Biopharma investment in Debt Financing - LENSAR, Inc. | 60 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2020-03-09 | PDL BioPharma Announces Appointment of Edward A. Imbrogno as Vice President and Chief Financial Officer |
Official Site Inspections
http://www.pdl.com Semrush global rank: 4.99 M Semrush visits lastest month: 1.69 K
Unable to get host informations!!!
Loading ... 